Did you know?

City Eye Centre specialises in the latest intravitreal treatments for Age-related Macular Degeneration (ARMD), Retinal Vein Occlusion and Diabetic Macular Oedema. We are also equipped with the latest diagnostic technology such as High Resolution OCT scanning and Optos wide-field angiography to accurately and promptly diagnose your condition.

We endeavour to deliver sight saving therapy utilizing Eylea, Lucentis, Avastin (these are termed Anti-VEGF drugs) and Triamcinolone, and have had many years of experience in this. Diagnosis involves OCT scanning, fluorescein angiography and in some instances ICG angiography.

Macular Degeneration (ARMD)

Early diagnosis and prompt treatment of macular degeneration with Eylea or Lucentis can be potentially sight saving. This is performed at the City Eye Centre using topical / local  anaesthetic to make the procedure as pain free as possible. Generally treatments are performed monthly until the ARMD subsides (an initiation/induction phase), then treatment is extended to around 6-8 weeks. Every patient however is treated with an individualized dosing strategy as part of your treatment plan. Long-term treatment is essential to maximize visual potential and maintain your vision (a maintenance phase).